Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Cash from Investing Activities (2019 - 2025)

aTYR PHARMA's Cash from Investing Activities history spans 7 years, with the latest figure at $16.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 370.22% year-over-year to $16.4 million; the TTM value through Dec 2025 reached -$5.1 million, down 129.32%, while the annual FY2025 figure was -$5.1 million, 129.32% down from the prior year.
  • Cash from Investing Activities reached $16.4 million in Q4 2025 per ATYR's latest filing, up from -$20.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $20.6 million in Q3 2022 to a low of -$49.3 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$2.6 million, with a median of $321500.0 recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: crashed 1640.68% in 2021, then soared 791.35% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$49.3 million in 2021, then skyrocketed by 104.05% to $2.0 million in 2022, then surged by 791.35% to $17.8 million in 2023, then crashed by 134.15% to -$6.1 million in 2024, then surged by 370.22% to $16.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Cash from Investing Activities are $16.4 million (Q4 2025), -$20.4 million (Q3 2025), and $3.3 million (Q2 2025).